Arkolith/Insider Trading/AUPH/Form 4

Miller Joseph M

Chief Financial OfficerAurinia Pharmaceuticals Inc. (AUPH) · full profile →Form 4 · filed Mar 3, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Tax withholding(F)38K$14.21$533K576K
Feb 27, 2026Grant(A)57K—$0614K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 27, 2026Grant(A)96K—$096K

Transaction Codes

F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001600620-26-000023) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML